Navigation Links
AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US
Date:9/18/2009

to the Form 8K filed with the Securities and Exchange Commission (SEC).

Radient Pharmaceuticals Corporations

Radient Pharmaceuticals is actively engaged in the research, development, manufacturing, sales and marketing of in vitro diagnostic (IVD) and high-end skin care products. The Company has completed a 5-year business strategy outlining its mission, vision, international commercialization plan, and future product development plans for both products. Simultaneously, Radient Pharmaceutical is aggressively collaborating with its China-based management team to determine the highest valuation path and plan for the de-consolidation of Jade Pharmaceuticals Inc. (JPI).

MacLellan continued, "Along with our corporate name change, we have restructured our business and are re-classifying Jade Pharmaceuticals as a business asset rather than a core operating arm of the Company. In doing this, we are now able to focus 100% of our work efforts on two critical priorities - successfully developing and delivering life-changing products that make a positive difference in the lives of the people we serve, which in turn will deliver exceptional returns to our valued and loyal shareholders. At the heart of our business is a straightforward commitment to deliver products that really matter and that commitment is the very essence of who we are."

Products

Onko-Sure(TM): a simple, non-invasive blood test used for the detection and/or monitoring of 14 different types of cancer.

  • Can be a valuable diagnostic tool in the worldwide battle against cancer, the second leading cause of death worldwide.
  • Serves the IVD cancer/oncology market which is growing at an 11% CAGR and is expected to reach $8B by 2012 according to healthcare market intelligence group Kalorama.
  • Sold as a blood test for cancer in Europe (C
    '/>"/>

SOURCE AMDL Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. LCA-Vision Announces CEO Resignation
2. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
3. Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock
4. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
5. Aethlon Medical, Inc. Announces Annual Meeting Results
6. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
7. Martek Announces Addition to Its Board of Directors
8. Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
9. BVGH Announces New Board Chair
10. Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target
11. Enerkem Announces Construction Start on Advanced Energy Research Facility in Edmonton, Alberta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... SAN DIEGO, Dec. 15 Aethlon Medical, ... that Dr. Jeff Schorey and Dr. Wayne Comper ... of Exosome Sciences, Inc. (ESI). Both Dr. Schorey ... exosome field. ESI, a wholly owned subsidiary of ... discovery that the Hemopurifier®, a medical device being ...
(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...
(Date:12/15/2009)... Dec. 15 On January 20th, 2010, ... for Medical Publication Professionals (ISMPP) will be held ... UK. More than 100 attendees are expected at ... publication professionals, editors, publishers, medical writers and medical ... publications and the impact of guidelines and regulations ...
(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...
Breaking Biology Technology:Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2
... YORK, April 21 Crystal Research Associates, LLC announced ... (EIO(R)) on ACT Biotech, Inc. The full 56-page report ... Biotech, Inc. ("ACT Biotech" or "the Company") is a ... and commercialization of novel cancer therapeutics. Following a technology ...
... Vantia Therapeutics, a,company developing novel small molecule ... appointment of Rachel Morten as Head of,Regulatory Affairs. ... than 24 years experience in global regulatory affairs ... industries. Most,recently an independent regulatory affairs consultant, Rachel ...
... Esther Chang describes the most recent developments in ... nanoparticle method designed to restore normal gene function ... April 21 at an American Association of Anatomists ... New Orleans. , Dr. Chang, a molecular oncologist, ...
Other Biology Technology:Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. 2Crystal Research Associates, LLC Issues an Executive Informational Overview(R) (EIO(R)) on ACT Biotech, Inc. 3Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs 2Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs 3Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs 4Fat droplet nanoparticle delivers tumor suppressor gene to tumor and metastatic cells 2
(Date:12/15/2009)... is available in German . , Leipzig: ... predicting the future distribution of mammals. This is the ... 140 indigenous European mammals. The researchers analysed data on ... as the phylogenetic information of the species. Judging by ... related species, mammals seem to adapt fast to changing ...
(Date:12/14/2009)... researchers are part of an international team that has ... to revise the history of North America,s woolly mammoths ... A Earth and Atmospheric Sciences professor Duane Froese and ... radiocarbon dating of bones and teeth. That analysis concluded ... North America (the ,megafauna,) disappeared about 13,000 years ago. ...
(Date:12/14/2009)... Biomedical Engineering Society (BMES) have founded a new journal ... CVET is a forum for research ... The first issue of the new quarterly journal ... BMES publications at Springer, Annals of Biomedical Engineering ... Cardiovascular Engineering and Technology will present a ...
Breaking Biology News(10 mins):Species distribution models are of only limited value for predicting future mammal distributions 2Biomedical Engineering Society's new journal to be published by Springer 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 15062 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 15062 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 15062 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 15062 4Cardium Files FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Topical Gel and ExcellagenFX 28TM 29 Flowable Collagen P 6732 1Cardium Files FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Topical Gel and ExcellagenFX 28TM 29 Flowable Collagen P 6732 2Cardium Files FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Topical Gel and ExcellagenFX 28TM 29 Flowable Collagen P 6732 3Cardium Files FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Topical Gel and ExcellagenFX 28TM 29 Flowable Collagen P 6732 4Cardium Files FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Topical Gel and ExcellagenFX 28TM 29 Flowable Collagen P 6732 5Jazz Pharmaceuticals Appoints Kathryn Falberg as Chief Financial Officer 6728 1
... single compound to increase the lifespan of obese mice, ... the changes in gene expression patterns found in mice ... diabetes, heart disease, and other significant diseases related to ... School and the National Institute on Aging, is the ...
... be perpetuated between generations by changes in the brain ... Chicago shows. , A research team found that when ... mild abuse in their first month of life, their brains ... the brain. Low levels of serotonin are associated with anxiety ...
... and threatening human well-being, according to a report published ... Science published by AAAS, the nonprofit science society. ... this trend has recently been accelerating," said lead author ... the consequences. For example, if the long-term trend continues, ...
Other Biology News:Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese 2Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese 3Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese 4Single molecule extends fat mice lives by reversing gene pathways associated with disease in obese 5Low levels of neurotransmitter serotonin may perpetuate child abuse across generations 2Low levels of neurotransmitter serotonin may perpetuate child abuse across generations 3By 2048 all current fish, seafood species projected to collapse 2By 2048 all current fish, seafood species projected to collapse 3
mitochondrial proteins (human heart) for 2-D gel electrophoresis *5 mg/mL*...
... undoubtedly the most complete and professional software ... layers and subsets makes it is possible ... data outputs, for example Cy3 and Cy5, ... as different subsets of genes and/or arrays. ...
...
...
Biology Products: